Peeling Back The Layers: Exploring AbbVie Through Analyst Insights
Peeling Back The Layers: Exploring AbbVie Through Analyst Insights
揭開層面：通過分析師見解探索 AbbVie
In the latest quarter, 8 analysts provided ratings for AbbVie (NYSE:ABBV), showcasing a mix of bullish and bearish perspectives.
在最近一個季度中，8位分析師爲艾伯維（紐約證券交易所代碼：ABBV）提供了評級，展現了看漲和看跌的混合前景。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表簡要介紹了他們最近的評級，展示了過去30天情緒的演變，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for AbbVie, revealing an average target of $189.75, a high estimate of $195.00, and a low estimate of $180.00. Witnessing a positive shift, the current average has risen by 3.12% from the previous average price target of $184.00.
分析師爲艾伯維設定了12個月的目標股價，顯示平均目標股價爲189.75美元，最高估計爲195.00美元，低估值爲180.00美元。當前的平均價格從之前的平均目標價184.00美元上漲了3.12％，這是一個積極的轉變。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：仔細觀察
An in-depth analysis of recent analyst actions unveils how...
對分析師近期行爲的深...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。